Amgen to acquire Horizon Therapeutics in $27.8bn deal
Horizon Therapeutics is a biotechnology company focused on discovering, developing, and marketing medicines that for rare, autoimmune, and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Dec 22
Horizon Therapeutics is a biotechnology company focused on discovering, developing, and marketing medicines that for rare, autoimmune, and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
12 Dec 22
The collaboration will leverage Kite’s experience in cell therapy manufacturing to co-develop and co-commercialise Arcellx’s lead candidate CART-ddBCMA,…
09 Dec 22
The European Commission (EC) approved Qdenga (TAK-003) for use in individuals aged four years and above, administered subcutaneously…
09 Dec 22
Based on platform, the point-of-care and rapid diagnostics market is segmented into lateral flow assays, immunoassays, microfluidics, dipsticks,…
08 Dec 22
Pfizer has received the FDA’s Prescription Drug User Fee Act (PDUFA) goal date of May 2023, for a…
07 Dec 22
This sparked the idea of using solely local capacities and products for humanitarian aid, as a result of…
NutraceuticalsProtein and Peptide Synthesis and Manufacturing
07 Dec 22
"We're so proud to welcome these newly certified partners into the Fairtrade community. Each of these brands showcase…
Brand Protection and Anti-counterfeitingMaintenance Management Systems
07 Dec 22
The two companies will jointly discover and develop a novel papain-like protease (PLpro) inhibitor oral antiviral candidate against…
06 Dec 22
The Phase 3 trial has met the primary endpoint of radiographic progression-free survival (rPFS) in PSMA-positive mCRPC who…
05 Dec 22
The investment, which forms part of Pfizer’s strategy to expand manufacturing capacity in Europe, will focus on the…